Close Menu

NEW YORK (360Dx) – Gradientech said today that it has raised 20 MSEK ($2.2 million) in equity funding from existing investors for the continued design and development of its microfluidic QuickMIC diagnostic system, which uses phenotypic bacteria growth analysis to enable rapid antibiotic testing and treatment of sepsis patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.